These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10914251)

  • 1. [Hepatic injury associated with use of nitrofurantoin].
    Karmon Y; Edoute Y
    Harefuah; 1999 Mar; 136(5):406-8. PubMed ID: 10914251
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fatal hepatitis from nitrofurantoin].
    Baccino E; Mottier D; Pennec Y; Jouquan J; Youinou P; Le Guillou M
    Ann Gastroenterol Hepatol (Paris); 1985 Jan; 21(1):51-2. PubMed ID: 3977278
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal liver necrosis associated with the use of nitrofurantoin.
    Edoute Y; Karmon Y; Roguin A; Ben-Ami H
    Isr Med Assoc J; 2001 May; 3(5):382-3. PubMed ID: 11411208
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute kidney injury, hepatitis, and CPK elevation associated with nitrofurantoin therapy.
    Beigel R; Perets R; Mouallem M
    Am J Med Sci; 2009 Feb; 337(2):132-3. PubMed ID: 19214031
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitrofurantoin and non-autoimmune hepatitis.
    Prieto de Paula JM; Martín-Luquero Ibáñez M; Franco Hidalgo S
    Med Clin (Barc); 2017 Apr; 148(8):382-383. PubMed ID: 28238334
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nitrofurantoin-induced lupus-like syndrome associated with hepatitis].
    Salle V; Lafon B; Smail A; Cévallos R; Chatelain D; Andréjak M; Ducroix JP
    Rev Med Interne; 2006 Apr; 27(4):344-6. PubMed ID: 16364504
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatic toxicity of nitrofurantoin. Cases reported to the Center for Monitoring Adverse Drug Reactions 1968-1998].
    Dam-Larsen S; Kromann-Andersen H
    Ugeskr Laeger; 1999 Nov; 161(48):6650-2. PubMed ID: 10643355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrofurantoin-induced lung- and hepatotoxicity.
    Koulaouzidis A; Bhat S; Moschos J; Tan C; De Ramon A
    Ann Hepatol; 2007; 6(2):119-21. PubMed ID: 17519837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risks of long-term nitrofurantoin prophylaxis in patients with recurrent urinary tract infection: a recent medico-legal case.
    Cetti RJ; Venn S; Woodhouse CR
    BJU Int; 2009 Mar; 103(5):567-9. PubMed ID: 18782308
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitrofurantoin toxicity to both liver and lungs.
    Yalçin S; Sahin A; Yalçin B; Altinok G
    Liver; 1997 Jun; 17(3):166-7. PubMed ID: 9249732
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe nitrofurantoin-induced adverse drug reactions: Is there a benefit of sequential therapy?
    Benyamine A; Granel B; Belenotti P; Masson E; Default A; Garcia S; Serratrice J; Weiller PJ
    Therapie; 2019 Oct; 74(5):553-556. PubMed ID: 31027709
    [No Abstract]   [Full Text] [Related]  

  • 12. Nitrofurantoin-induced immune-mediated lung and liver disease.
    Milić R; Plavec G; Tufegdzić I; Tomić I; Sarac S; Loncarević O
    Vojnosanit Pregl; 2012 Jun; 69(6):536-40. PubMed ID: 22779302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrofurantoin immune-mediated drug-induced liver injury: a serious complication of a commonly prescribed medication.
    Hydes T; Wright M; Jaynes E; Nash K
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24599428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrofurantoin-induced chronic active hepatitis.
    Amit G; Cohen P; Ackerman Z
    Isr Med Assoc J; 2002 Mar; 4(3):184-6. PubMed ID: 11908259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrofurantoin-induced immune-mediated lung and liver disease.
    Schattner A; Von der Walde J; Kozak N; Sokolovskaya N; Knobler H
    Am J Med Sci; 1999 May; 317(5):336-40. PubMed ID: 10334121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrofurantoin lung injury.
    Bidad K; Harries-Jones R
    Age Ageing; 2004 Jul; 33(4):414-5. PubMed ID: 15226112
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitrofurantoin: friend or foe?
    Kapral N; Saxena R; Sule AA; Markle B
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30115718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrofurantoin-induced hepatotoxicity mediated by CD8+ T cells.
    Kelly BD; Heneghan MA; Bennani F; Connolly CE; O'Gorman TA
    Am J Gastroenterol; 1998 May; 93(5):819-21. PubMed ID: 9625135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrofurantoin-induced hepatotoxicity: a rare yet serious complication.
    Sakaan SA; Twilla JD; Usery JB; Winton JC; Self TH
    South Med J; 2014 Feb; 107(2):107-13. PubMed ID: 24926677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Common Are Pulmonary and Hepatic Adverse Effects in Older Adults Prescribed Nitrofurantoin?
    Claussen K; Stocks E; Bhat D; Fish J; Rubin CD
    J Am Geriatr Soc; 2017 Jun; 65(6):1316-1320. PubMed ID: 28306135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.